ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
China · Delayed Price · Currency is CNY 32.21
-0.49 (-1.50%)
Mar 19, 2026, 1:45 PM CST
SHE:300723 Revenue
ApicHope Pharmaceutical Group had revenue of 230.21M CNY in the quarter ending September 30, 2025, a decrease of -29.66%. This brings the company's revenue in the last twelve months to 1.02B, down -45.90% year-over-year. In the year 2024, ApicHope Pharmaceutical Group had annual revenue of 1.45B, down -42.07%.
Revenue (ttm)
1.02B
Revenue Growth
-45.90%
P/S Ratio
14.33
Revenue / Employee
690.30K
Employees
1,484
Market Cap
14.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.45B | -1.05B | -42.07% |
| Dec 31, 2023 | 2.50B | 223.25M | 9.79% |
| Jan 1, 2023 | 2.28B | 80.98M | 3.68% |
| Dec 31, 2021 | 2.20B | 523.80M | 31.26% |
| Dec 31, 2020 | 1.68B | 38.01M | 2.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Shyndec Pharmaceutical | 9.36B |
| Zhejiang Medicine | 8.96B |
| Guobang Pharma | 5.94B |
| Shenzhen Hepalink Pharmaceutical Group | 5.38B |
| Zhejiang Jiuzhou Pharmaceutical | 5.36B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 2.98B |
| Shanghai Haoyuan Chemexpress | 2.87B |
| Shenzhen Kangtai Biological Products | 2.70B |